Italy Contraceptive Devices Market Report 2022 to 2030

Italy Contraceptive Devices Market Analysis

$ 3999

Italy's Contraceptive Devices Market is expected to witness growth from $310 Mn in 2022 to $552 Mn in 2030 with a CAGR of 7.50% for the forecasted year 2022-30. In Italy, awareness of and demand for contraceptive techniques are growing as a result of improved access to healthcare facilities and greater educational activities. This is especially true for younger generations who are more willing to use contraceptive methods. The market is segmented by type and by gender. Some key players in this market include Farmaceutici Formenti, Dompé, Mylan Laboratories, Church & Dwight, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.

ID: IN10ITMD005 CATEGORY: Medical Devices GEOGRAPHY: Italy AUTHOR: Jigyasu Bhandari

Buy Now

Italy Contraceptive Devices Healthcare Market Executive Analysis

Italy's Contraceptive Devices Market is expected to witness growth from $310 Mn in 2022 to $552 Mn in 2030 with a CAGR of 7.50% for the forecasted year 2022-30. Health spending in Italy is anticipated to be lower than in other Western European nations in 2022, at 9.39% of GDP. About 79.36% of all health expenditures in 2022 were covered by public funds, with households paying the majority of the remaining costs (21.64%) out of their own pockets.

More than 35,000 cases of syphilis were reported in Italy in 2022. 58 cases per 100,000 people was the incidence rate. In Italy in 2019, there were over 110,000 instances of chlamydia, making it the most often reported STI. 182 cases per 100,000 people was the incidence rate. In 2020, Italy had a maternal mortality ratio of 2 deaths per 100,000 live births. In comparison to the global maternal mortality ratio of 211 deaths per 100,000 live births, this is a comparatively low number. In Italy, contraceptive methods are extensively utilised and come with a number of advantages and benefits for users. When used appropriately and consistently, contraceptive methods are quite successful at preventing unplanned pregnancies. For those who are not ready for children or do not want any children at all, this is very crucial. By creating a physical barrier or limiting the number of partners, contraceptive methods can help lower the risk of STDs. In addition to regulating menstrual periods, hormonal contraceptives can ease premenstrual syndrome symptoms. With the aid of contraceptive methods, women can have more control over their reproductive health and be better equipped to plan for the future. Women are better equipped to pursue educational and professional opportunities and increase their economic stability by preventing unwanted pregnancies. Unwanted pregnancies can have a huge financial impact on both the patient and the healthcare system. Contraceptive methods can assist in lowering these expenditures and enhancing general healthcare outcomes by preventing unplanned pregnancies.

Italy Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

In Italy, awareness of and demand for contraceptive techniques are growing as a result of improved access to healthcare facilities and greater educational activities. This is especially true for younger generations who are more willing to use contraceptive methods. Technological developments have led to the development of more potent and advanced contraceptive methods. For example, long-acting reversible contraceptives, such as hormonal and non-hormonal IUDs, are becoming more and more popular among women in Italy due to their high rates of efficacy and simplicity. Italy's population is growing older, which is predicted to boost older women's demand for contraceptive methods to avoid unexpected pregnancies.

Market Restraints

In Italy, for certain people, especially those who lack insurance or have restricted access to healthcare facilities, the price of contraceptive methods might be a significant obstacle. The adoption of contraceptive methods may be hampered by high costs, especially among marginalised and low-income groups. In Italy, social and cultural norms may restrict the use of contraceptive methods, particularly in more conservative neighbourhoods where attitudes towards contraception may be unfavourable.

Competitive Landscape

Key Players

Farmaceutici Formenti (IT)
Dompé (IT)
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Pregna International
Teva Pharmaceutical

Recent Notable Deals

2022: The distributor of medical goods, including contraceptive devices, Medisafe Distribution, was purchased in 2022 by the Italian pharmaceutical company Dompé for a majority interest. The acquisition is anticipated to aid Dompé in strengthening its medical device portfolio and establishing a stronger foothold in the Italian healthcare industry.

Healthcare Policies and Regulatory Landscape

The Italian Medicines Agency (AIFA) and the Ministry of Health are in charge of regulating the healthcare system and the regulatory environment for contraceptive devices in Italy. Contraceptive contraptions are categorised as medical devices and are therefore governed by AIFA. Every medical device sold in Italy must be registered with AIFA and adhere to the standards outlined in both the Italian Medical Devices Regulation and the European Medical Device Regulation (MDR). In order to use certain contraceptive methods in Italy, such as hormonal contraceptives and intrauterine devices, a doctor's prescription is necessary. Patients can get a prescription by going to a medical professional, like a gynaecologist or a family physician.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.